N17D (p.Asn17Asp) variant of ANK2 (Ankyrin-2)

N17D (p.Asn17Asp) in ANK2 (Ankyrin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes population frequency data, experimental measurements, and structural context.

N17D (p.Asn17Asp) variant details